USA Financial Formulas
RPRX icon

USA Financial Formulas’s Royalty Pharma RPRX Stock Holding History

USA Financial Formulas’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$192K Sell
3,290
-1,149
-26% -$67.8K 0.04% 133
2026
Q2 		$249K Buy
+4,439
New +$231K 0.05% 111
2025
Q4 		– Sell
-7,321
Closed -$258K – 464
2025
Q3 		$258K Buy
7,321
+6,428
+720% +$233K 0.05% 124
2025
Q2 		$32.2K Buy
+893
New +$29.6K 0.01% 210

Other funds holding RPRX

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Hosking Partners
Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return
Kepler Cheuvreux
Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Kirr Marbach & Co
Kirr Marbach & Co Columbus, Indiana $530M AUM 14.37% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

USA Financial Formulas's RPRX Position: Q3 2026 in Review

USA Financial Formulas reduced its Royalty Pharma (RPRX) stake by 26% in Q3 2026, selling an estimated $67.8K and leaving 3,290 shares worth $192K. The position accounts for 0.04% of the portfolio, ranked #133.

USA Financial Formulas first reported a position in RPRX in Q2 2025 and has held it in 4 quarters since. The position peaked at $258K in Q3 2025. 129 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • USA Financial Formulas held 3,290 shares of Royalty Pharma worth $192K as of Q3 2026.
  • USA Financial Formulas sold 1,149 Royalty Pharma shares in Q3 2026, an estimated $67.8K.
  • Royalty Pharma made up 0.04% of USA Financial Formulas's portfolio in Q3 2026, its #133 holding.
  • USA Financial Formulas first reported a position in Royalty Pharma in Q2 2025 and has held it in 4 quarters since.
  • USA Financial Formulas's Royalty Pharma position peaked at $258K in Q3 2025.
  • 129 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on USA Financial Formulas's 13F filing for Q3 2026, filed 16 Oct 2026.